CN103479664A — 一种液态口服补液盐
Assigned to Beijing Yiling Medical Science and Technology Development Co., Ltd. · Expires 2014-01-01 · 12y expired
What this patent protects
本发明提供一种液态的口服补液盐,包含氯化钠0.056~0.96%,氯化钾0.034~0.042%,枸橼酸钠0.065~0.079%,葡萄糖0.31~0.37%,水94.5~104.5%,用于治疗腹泻引起的轻中度脱水以及治疗儿童腹泻引起的脱水。通过精确控制水的用量,无菌处理等使得高液态补液盐质量稳定,使用更加方便,更好的发挥药效,适用于老人、儿童以及在野外、紧急等缺水条件下服用。
USPTO Abstract
本发明提供一种液态的口服补液盐,包含氯化钠0.056~0.96%,氯化钾0.034~0.042%,枸橼酸钠0.065~0.079%,葡萄糖0.31~0.37%,水94.5~104.5%,用于治疗腹泻引起的轻中度脱水以及治疗儿童腹泻引起的脱水。通过精确控制水的用量,无菌处理等使得高液态补液盐质量稳定,使用更加方便,更好的发挥药效,适用于老人、儿童以及在野外、紧急等缺水条件下服用。
Drugs covered by this patent
- Micro-K 10 (POTASSIUM CHLORIDE) · Nesher Pharms
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.